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1 |  INTRODUCTION
Considering the persistent major challenges in the clinical 
management of epilepsies, there is a continued need for animal 
experiments identifying and assessing strategies that aim to 
overcome drug resistance, to interfere with pathophysiological 
mechanisms, and to prevent epilepsy.1‒4 As pointed out previ-
ously, experimental in vivo studies require a thorough ethical 
justification with a careful harm‐benefit  analysis.5 In many 
countries, along with the request for an animal experiment 
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Abstract
Objective: Considering the complexity of neuronal circuits and their epilepsy‐as-
sociated alterations, epilepsy models cannot be completely replaced by in vitro ex-
perimental approaches. Decisions about ethical approval of in vivo studies require 
a thorough weighing of the animal's burden and the benefit regarding the expected 
gain in knowledge.
Methods: Based on combined behavioral, biochemical, and physiological analyses, 
we assessed the impact on animal well‐being and condition in different phases of the 
pilocarpine post–status epilepticus (SE) model in rats.
Results: As a consequence of SE, increased levels of impairment were evident in 
the early postinsult phase and late chronic phase, whereas only mild impairment was 
observed in the interim phase. Parameters that stood out as sensitive indicators of 
animal distress include burrowing, which proved to be affected throughout all ex-
perimental phases, saccharin preference, fecal corticosterone metabolites, heart rate, 
and heart rate variability.
Significance: The cumulative burden with temporary but not long‐lasting phases 
of more pronounced impairment suggests a classification of severe as a basis for 
laboratory‐specific prospective and retrospective evaluation. Among the parameters 
analyzed, burrowing behavior and saccharin preference stand out as candidate pa-
rameters that seem to be well suited to obtain information about animal distress in 
epileptogenesis models.
K E Y W O R D S
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allowance, scientists have to categorize the animal model 
according to severity classification schemes.6 The different 
classifications of severity according to the European Union 
Directive 2010/63 include nonrecovery, mild, moderate, and 
severe. The classification is based on the pain, suffering, dis-
tress, or lasting harm animals can experience regarding the 
performed procedures.7 This suggestion is then evaluated by 
regulatory authorities and ethical committees, providing the 
basis for the recommendation or decision to approve or reject.
This procedure has to deal with well‐known uncertainties in 
judging and assessing the well‐being of animals and the burden 
associated with interventions and disease models. Thus, there 
is an urgent need to replace subjective opinion–based decision‐ 
making with scientific approaches, and to develop evidence‐based 
severity assessment schemes for epilepsy models. Respective 
 efforts will even more importantly provide an improved basis to 
assess refinement measures and minimize severity.5,8
In a previous study, we have evaluated the impact of focal 
and generalized kindled seizures on the well‐being of rats 
based on the analysis of various behavioral and biochemical 
parameters.5 Taken together, the data suggested a categoriza-
tion as a model with moderate severity based on a longer‐last-
ing mild behavioral alteration.5
First described by Turski et al,9 the application of the pilo-
carpine model has increased over time so that the model rep-
resents one of the most frequently applied chronic epilepsy 
rodent models in the field of epileptology. The model is based 
on chemical induction of status epilepticus (SE) by systemic 
administration of the direct parasympathomimetic drug.10‒12 
As a consequence of the SE, rats develop spontaneous seizures 
following a latency phase.10 The model is characterized by ex-
tensive brain lesions, which are accompanied by pronounced 
behavioral alterations.10 Considering the widespread use of 
the pilocarpine model, it is of particular relevance to provide 
a scientific basis for the severity classification of the model.
In the past, efforts have been made to optimize the model 
by adjusting the pilocarpine administration protocol and by 
pretreatment.10,13 However, respective approaches have mostly 
focused on a limitation of the mortality rates as a major issue 
in the application of the paradigm. As emphasized by Lidster 
et al,8 further efforts should be made to optimize the protocols 
of post‐SE models, including the pilocarpine model, consid-
ering animal welfare aspects. Against the background of an 
evidence‐based severity assessment, we have comprehensively 
analyzed the impact of the rat pilocarpine post‐SE model on 
behavioral patterns and biochemical parameters. In addition, 
analysis of telemetric data provided information on different 
experimental phases regarding circadian activity and heart rate 
patterns as well as heart rate variability as further distress‐as-
sociated readout parameters. This allowed us not only to assess 
the severity in this post‐SE model but also to directly compare 
the different parameters and to suggest candidate parameters 
that best indicate an increased burden for the animal.
This study consists of two separate subprojects. In one 
subproject, electroencephalogram (EEG) was recorded with 
a tethered connection and behavioral and biochemical param-
eters were investigated. In the other subproject, EEG was re-
corded telemetrically, which in addition to biochemical and 
behavioral parameters made it possible to investigate home 
cage activity and heart rate patterns.
One final note is that this study is part of a series in which 
the severity classification of three common rat epilepsy models 
(I, kindling model, published by Möller et al.5,14; II, chemical 
post‐SE model in the present study and III, electrical post‐SE 
model, published by Seiffert et al.15) is determined using identi-
cal behavioral and biochemical and physiological analyses. The 
main aim of these studies is to determine the impact of different 
experimental phases of these chronic epilepsy models on the 
well‐being of the animals. Another aim is the identification of 
parameters that are most informative in terms of assessing se-
verity levels. The findings of this study will be considered in 
future efforts of our national research consortium (https ://sever 
ity-asses sment.de) to define and validate composite measure 
schemes for severity assessment. Respective studies will assess 
the generalizability and robustness of selected parameters and 
composite measurement schemes based on multicenter studies.
2 |  MATERIALS AND METHODS
2.1 | Animals and experimental groups
In total, 62 female Sprague Dawley rats (180‐220 g, Envigo) 
were used for this study. Animals were housed individu-
ally and under controlled conditions (45%‐65% humidity, 
22‐24°C, 12 hours, regular, light/dark cycle). Food and tap 
water were freely available. Every week the animals re-
ceived a Makrolon type III cage with new bedding material 
(Lignocel Select, J. Rettenmaier & Söhne) and new nesting 
material (Enviro‐Dri, Claus GmbH, Neuwied Germany).
Key Points
• The data indicate that the assessment of burrow-
ing behavior and saccharin preference can serve 
as indicators of impaired well‐being in rats
• During the latency phase, the impact on well‐
being is rather mild
• Impairment of well‐being reaches higher levels 
during the early postinsult phase and intermediate 
levels during the chronic phase
• First evidence has been obtained that telemetric 
recordings of EEG may serve as a refinement 
measure in comparison to recordings with a teth-
ered monitoring setup
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For the subproject using tethered recordings, 44 animals were 
randomly divided into three experimental groups (www.rando 
mizer.org), a naive (n  =  12 animals, without implant), sham 
(n  =  12 animals, with implant), and pilocarpine‐treated teth-
ered (n = 20 animals, with implant and treated with pilocarpine) 
group. For the subproject using telemetric recording, 18 animals 
were divided into two groups in a randomized manner (www.
rando mizer.org): sham (n = 6 animals, electrode and transmitter 
implanted) and pilocarpine‐treated telemetric (n = 12 animals, 
electrode and transmitter implanted and pilocarpine‐treated). 
The two subprojects (telemetric and tethered recorded) were per-
formed separately. Taking into account the cost‐intense telemetry 
system, overall n was lower in the tethered subproject, and due 
to the required telemetry device, no true naive group (ie, no in-
tervention) could be included. Animals were weighed regularly 
and controlled according to the severity assessment schemes. 
Additionally, the Grimace scale and the Irwin score were as-
sessed. At the end of project, rats were euthanized by an overdose 
of pentobarbital (600 mg/kg intraperitoneal, Narcoren, Merial). 
Afterward, adrenal glands were sampled and weighed. This study 
was conducted following approval by the government of Upper 
Bavaria (reference number: AZ 55.2‐1‐54‐2532‐105‐16) and was 
in line with the German Animal Welfare act, the ARRIVE guide-
lines concept, and the Basel declaration including the 3R concept.
2.2 | Electrode and transmitter 
implantation and induction of SE
Electrodes were implanted in the right dentate gyrus of the hip-
pocampus (anteroposterior, −3.9  mm; lateral,  +1.7  mm; ven-
tral, +4.1 mm relative to bregma.16 The surgical procedure was 
performed according to Di Liberto et al.17 The surgery was per-
formed under aseptic conditions. Two animals assigned to the 
pilocarpine group in the tethered group died during surgery. 
Following a recovery period of 2 weeks, SE was induced as de-
scribed by Di Liberto et al17; see Data S1 for a more detailed 
description of both the implantations and the induction of SE. A 
total of four of the remaining 30 animals died after diazepam in-
jections, resulting in a final n of 15 pilocarpine‐treated animals in 
the tethered group and 11 treated animals in the telemetric group.
2.3 | Tethered and telemetric recordings
To confirm the development of spontaneous recurrent seizures 
(SRSs), video/EEG monitoring was performed. Monitoring and 
analysis in the tethered group was done as described by Walker 
et al.18 Monitoring in the telemetry group was done as described 
by Möller et al.14 In addition to the monitoring period during 
the chronic phase, recordings were made before induction of SE 
(baseline), and 7 days (early postinsult phase) and 4 weeks post‐
SE (latency phase) for investigating electrocardiogram (ECG).
Analysis of ECG was done using Ponemah Software 6.41 
(Data Sciences International). In addition to the time‐domain 
parameters, for the frequency‐domain parameter the ratio 
between low‐ and high‐frequency bands (LF/HF with 
LF = 0.1‐1.0 Hz and HF = 1.0‐3.5 Hz) was calculated accord-
ing to Thireau et al.19 EEG recordings were analyzed using 
NeuroScore Software 3.0 (Data Sciences International).
2.4 | Behavioral and 
biochemical parameters
The behavioral tests were performed according to previ-
ous studies conducted in our facility.5,17,20 Behavioral as-
sessments were made at different time points throughout 
the study. Nest‐building activity, burrowing behavior, the 
Grimace scale, and the Irwin score were analyzed repeatedly 
during different phases of the study. Social interaction test, 
burrowing paradigm, open field, black‐white box, elevated‐
plus maze, and saccharin preference test were assessed dur-
ing the chronic phase. Throughout the study, fecal samples 
were used to quantify corticosterone metabolites. At the end 
of the project, hair samples were collected for the determina-
tion of corticosterone levels and serum for the investigation 
of brain‐derived neurotrophic factor (BDNF) and corticos-
terone levels. Analyses of the biochemical parameters were 
done as described previously by Möller et al.5 The timelines 
of the two different subprojects can be found in Figure 1.
2.5 | Statistics
GraphPad Prism (v5.04) was used for the statistical analysis. 
Comparisons of naive versus sham and sham versus post‐SE 
were tested using an unpaired t test. For the analyses of datasets 
of the naive, sham, and post‐SE groups, a two‐way repeated 
measure analysis of variance was performed. Additionally, a 
Bonferroni post hoc test was performed for individual com-
parisons. For the visualization of the telemetric recordings, the 
correlation matrix and principal component analysis (PCA), R 
version 3.3.2,21 with the R packages ggplot2,22 corrplot,23 and 
made4,24 were used. A Loess regression with a span of 0.15 
was used to smooth the line graphs in Figure 5 and Figure S7.
3 |  RESULTS
3.1 | Induction of SE and development of 
spontaneous recurrent seizures
SE in both subprojects was induced by fractionated injections 
of pilocarpine in 30 rats. Following the first injection of pilo-
carpine, animals exhibited head nodding, tremor, facial clo-
nus, immobility, and chewing. After two to four injections, all 
animals developed SE. During the video/EEG monitoring in 
the tethered group, 13 of 15 animals exhibited SRSs. One ani-
mal showed handling‐associated generalized seizures. Over 
the whole monitoring period of 14  days, the mean seizure 
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frequency was 29.4 (Figure S1A, SD = 46.2, median = 11.5) 
and the mean total seizure duration was 39.2 minutes (Figure 
S1B, SD = 50.6, median = 15.6). All animals with telemetric 
recordings developed SRSs following induction of SE. The 
mean number of SRSs in this group amounted to 22.6 (Figure 
S1A, SD = 39.5, median = 3) and the mean seizure duration 
to 34.5 minutes (Figure S1B, SD = 45.9, median = 13.8). No 
significant difference in seizure frequency or duration was 
found between the tethered and telemetric groups.
3.2 | Impact on nest‐building
In the early postinsult phase (5 days following SE) and the la-
tency phase (4 weeks following SE), nest complexity scores 
proved to be in the control range in both subprojects (Figure 
S3A‐D). In the chronic phase following video/EEG monitor-
ing, only those animals with telemetric recordings exhibited 
a significant reduction in nest scores (Figure 2B).
3.3 | Impact on the Grimace scale, and 
behavior in the burrowing paradigm and the 
open field
Grimace scale scores were compared against known base-
line values,25 as blinded group comparisons could not be 
made due to the naive group not having implants. Analysis 
of the Grimace scale in the postsurgical phase revealed a 
difference in the recovery period regarding the electrode 
only versus combined electrode and transmitter implan-
tation in both subprojects. The animals experiencing the 
longer‐lasting surgery showed an altered Grimace scale 
until day 6 (Figure S8B), whereas animals with single elec-
trode implantation exhibited an increased Grimace scale 
until day 4 (Figure S8A) compared to baseline Grimace 
scores. Animals scored higher on both the Grimace scale 
and Irwin score when comparing the early postinsult 
phases to latency and chronic phase (Figure S8C‐F) in both 
subprojects.
As we will report in a separate article (Talbot et  al, in 
preparation) presenting and discussing a series of examples 
from various experimental paradigms with a focus on body 
weight development in the context of humane endpoint deci-
sions, a transient drop of body weight characterized the very 
early phase following SE in both subprojects (data not shown).
The surgical procedure remained without consequences 
on burrowing behavior in animals with electrode implanta-
tion and animals with electrode and transmitter implantation 
1  week following the intervention, and at later time points 
during the experiment (Figure 3A,B,D,F). Following SE, the 
amount of gravel burrowed proved to be significantly reduced 
in stimulated animals in both subprojects throughout the en-
tire study (Figure 3B‐G).
Whereas the time to onset of burrowing behavior re-
mained unaffected in the group of animals with telemetry 
F I G U R E  1  Timeline of study with tethered recordings (A) and timeline of study with telemetric recordings (B). EEG, 
electroencephalographic; SE, status epilepticus
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transmitters during the early postinsult and latency phase 
(Figure 3J,L), a persistent increase of the latency time be-
came evident as a short‐ and long‐term consequence of SE in 
animals without transmitters (Figure 3I,K,M).
Except for the reduced immobility frequency, behav-
ior in the open field was not altered in animals with SE 
in either subproject (Figure S2). The frequency of im-
mobility proved to be lower in animals with SE in both 
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subprojects as compared to respective control groups 
(Figure 2C,D).
3.4 | Impact on social 
interaction, and anxiety‐associated and 
anhedonia‐associated behavior
In the subproject with the tethered recorded animals, chronic 
electrode implantation (ie, sham animals) did not exert rel-
evant effects on the time spent in active social interaction 
(Figure 2E). In rats with SRSs, social interaction was af-
fected in a negative manner, resulting in a shorter total time 
spent with active interaction (Figure 2E,F). This effect was 
observed in animals with tethered and telemetric recordings.
In the elevated‐plus maze paradigm, behavioral patterns 
including the time spent in different areas and the distance 
moved did not differ between groups independent of moni-
toring method (Figure S4). However, for several parameters 
a higher level of interindividual variance became evident in 
the group of animals with epilepsy. Moreover, the animals 
exposed to the tethered recordings exhibited a significantly 
lower number of head dips (Figure S4G).
In the black‐white box, animals with epilepsy in both sub-
projects displayed reduced stretching behavior in comparison 
with the respective control groups (Figure 2G,H). In this para-
digm, none of the other parameters was affected as a long‐term 
consequence of SE and epilepsy manifestation (Figure S5).
A reduced consumption of saccharin was revealed in 
animals with epilepsy, which were previously exposed to 
tethered recordings (Figure 2I). In contrast, animals with 
telemetric seizure monitoring did not confirm a significant 
alteration in saccharin preference (Figure 2J).
3.5 | Impact on biochemical parameters
Analysis of samples from animals with electrode implants 
did not confirm alterations in adrenal gland weight or 
concentrations of BDNF and corticosterone (Figure 4A,C, 
Figure S6B).
In all rats with epilepsy, serum BDNF and hair corticosterone 
levels remained unaffected at the end of the projects (Figure S6). 
However, in rats with SRSs and a history of tethered recordings, 
the adrenal gland weight and fecal corticosterone metabolite 
(FCM) levels were increased (Figure 4A,E). Whereas FCM con-
centrations were in the control range during the latency phase, 
an early increase was evident 2 days following SE. Surprisingly, 
serum corticosterone levels proved to be decreased in this group 
of animals at the end of the experiment (Figure 4C). Here, eight 
animals (two naive, one sham, and five epilepsy) proved to have 
corticosterone levels below detectable levels; however, the dis-
tribution of these animals is in line with the found group differ-
ences, where the majority (five of eight) of these animals belong 
to the epilepsy group. Considering this outcome, we addition-
ally analyzed selected parameters reflecting activation of the 
hypothalamic‐pituitary‐adrenal gland axis in rats with previous 
telemetric recordings of spontaneous seizures. In these animals, 
adrenal gland weight as well as serum corticosterone and FCM 
levels proved to be in the control range except for a reduction of 
FCMs 7 days following SE (Figure 4B,D,F).
3.6 | Impact on home cage activity, heart 
rate, and heart rate variability
These parameters were investigated only in animals with tel-
emetric devices. Home cage activity levels monitored during 
different experimental phases were compared with baseline 
data and with prospective controls at the same time point.
Recordings from the early postinsult phase and the latency 
phase demonstrated that the SE history resulted in higher lev-
els of home cage activity during the dark phase (= activity 
phase) in comparison to controls. The impact of SE on dark 
phase activity is further reflected by differences compared 
to their baseline values during the early postinsult and the 
latency phase (Figure S7).
F I G U R E  2  Nest‐building, social interaction, and anxiety‐associated and anhedonia‐associated behavior recorded during the chronic phase. 
A, B, Nest complexity score in the chronic phase of the tethered (A) and telemetric (B) groups. A significant reduction of nest complexity was 
observed in the animals with epilepsy in the telemetrically recorded animals (P = .158) but not in the tethered group. C, D, Locomotor activity 
in the open field (OF) during the chronic phase. The animals of the tethered (C; F2, 35 = 20.65, P < .0001, epilepsy against both control groups 
P < .0001) as well as the telemetrically recorded (D; P = .0221) epilepsy group showed a significant decrease of immobility. E, F, Time in 
active social interaction during the chronic phase of the tethered (E; F2, 16 = 44.87, P = .2580, epilepsy against both control groups P < .0001) 
and telemetrically recorded (F; P < .0001) epilepsy animals. One data point for each pair is presented (tethered group: naive, n = 6; sham, n = 6; 
epilepsy, n = 7; telemetry group: sham, n = 3, epilepsy, n = 6). In both groups, animals that exhibited spontaneous recurrent seizures (SRSs) 
showed a significant reduction in active social interaction. G, H, Stretching postures in the black‐white box (BWB) during the chronic phase. 
Both the tethered (G; F2, 35 = 5.961, P = .0509, epilepsy against both control groups P < .05) and telemetrically recorded (H; P = .0488) animals 
with SRSs showed a significant reduction of stretching postures in the BWB compared to control groups. I, J, Saccharin consumption during the 
chronic phase of the tethered epilepsy group (I; F2, 34 = 14.18, P = .0003, epilepsy against both control groups P < .001) was significantly reduced, 
whereas the telemetric epilepsy group (J) did not show a difference. Two animals were excluded due to leaking drinking bottles (one sham and one 
epilepsy). Error bars indicate standard error of the mean. *P < .05. Total n for the tethered group: naive, n = 12; sham, n = 12; epilepsy, n = 14. 
Total n for the telemetry group: sham, n = 6; epilepsy, n = 10
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Both day and night heart rate reached higher levels in the 
early postinsult, latency, and chronic phases (Figure 5A,B). 
Thereby, differences to implanted control animals were de-
tected during all phases of epileptogenesis.
The total variability of heart rate was analyzed based on 
the standard deviation of NN (normal to normal R‐peaks) 
intervals (SDNN). The analysis revealed a decreased SDNN 
during the early postinsult phase in comparison to baseline 
values (Figure 5C,D). Throughout epileptogenesis, light 
phase (=resting phase) SDNN in implanted control animals 
exceeded that in animals with SE. During the dark phase, 
SDNN proved to be decreased in rats with SE in the early 
postinsult and the latency phase.
None of the parameters of short‐term variability (root 
mean square of successive differences [RMSSD], percentage 
of subsequent NN intervals that deviate more than 9 millisec-
onds [NN9], proportion derived by dividing NN9 by the total 
number of NN intervals [pNN9]) was altered.
F I G U R E  3  Burrowing behavior in the postsurgical phase, during epileptogenesis, and following epilepsy manifestation. A, Postsurgical 
weight of burrowed gravel. No significant difference was observed between groups. B‐G, Burrowed weight during the early postinsult phase (B, 
tethered animals, F2, 35 = 36.14, P = .0008, post–status epilepticus [SE] against both control groups P < .0001; C, telemetrically recorded animals, 
P = .0134), the latency phase (D, tethered, F2, 35 = 14.28, P = .0008, post‐SE against both control groups P < .001; E, telemetrically recorded, 
P = .0354), and chronic phase (F, tethered, F2, 35 = 11.06, P = .0011, epilepsy against both control groups P < .01; G, telemetrically recorded, 
P = .0042; no data for two epileptic animals due to measurement errors). During all phases, the animals with SE showed a significant reduction 
of burrowing behavior as compared to the control groups. H, Time to onset of burrowing behavior after surgery. No significant difference was 
observed. I, K, M, Time to onset of burrowing behavior in early postinsult (I; F2, 35 = 17.33, P < .0001, post‐SE against both control groups 
P < .0001), latency (K; F2, 35 = 28.85, P = .0004, post‐SE against both control groups P < .0001), and chronic phases (M; F2, 35 = 6.756, 
P < .0001, epilepsy against both control groups P < .05). Animals with a history of SE exhibited a significant increase during all phases post‐SE 
in the onset of burrowing behavior. J, L, With the exception of the chronic phase (N, P = .0302), animals with telemetric recordings did not show 
a significant difference regarding the onset of burrowing behavior (N: no data for two epileptic animals due to measurement errors). Error bars 
indicate standard error of the mean. *P < .05, **P < .01, ***P < .001, ****P < .0001. Total n for the tethered group: naive, n = 12; sham, n = 12; 
epilepsy, n = 14. Total n for the telemetry group: sham, n = 6; epilepsy, n = 11
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In addition to the time‐domain analysis, a frequency‐
domain analysis was performed by analyzing the ratio 
between low‐ and high‐frequency bands. No significant 
differences were observed as a consequence of SE (Figure 
S10).
3.7 | Correlation matrix of all 
measured variables
Two correlation matrices illustrating the Spearman correla-
tion coefficients between the majority of measured variables 
F I G U R E  4  Activation of hypothalamic‐pituitary‐adrenal axis. A, Animals with tethered recordings exhibited a significant increase of 
adrenal gland weight during the chronic phase in comparison to the sham group (F2, 35 = 3.659, P = .0361, epilepsy against sham P < .05). B, In 
the telemetrically recorded group, no difference from control groups was evident during the chronic phase. C, Serum corticosterone levels in the 
tethered epilepsy group were significantly reduced as compared to the naive group during the chronic phase (F2, 27 = 3.561, P = .0076, epilepsy 
against naive P < .05, a total of eight animals [two naive, one sham, and five epilepsy] were removed due to serum levels below detectable levels; 
the distribution of these low values are in line with the found group differences, where the epilepsy group showed significantly lower values). D, 
This effect was not observed in the telemetrically recorded group. E, In the tethered epilepsy group, a significant increase in fecal corticosterone 
metabolite (FCM) levels was observed 2 days (F2, 35 = 10.72, P = .0002, epilepsy against both control groups P < .001) and 13 weeks after SE 
induction (F2, 35 = 6.549, P < .0001, epilepsy against both control groups P < .05). F, In the telemetrically recorded post‐SE group, a significant 
decrease in FCM levels was observed 1 week after SE (P = .0357). Error bars indicate standard error of the mean. *P < .05, **P < .01, 
***P < .001. Total n for the tethered group: naive, n = 12; sham, n = 12; epilepsy, n = 14. Total n for the telemetry group: sham, n = 6; epilepsy, 
n = 9‐11
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were calculated, one for animals prepared for tethered re-
cordings (Figures 6 and Table S2 for an overview of abbre-
viations used) and one for animals prepared for telemetric 
recordings (Figure S9). As the number of significant correla-
tions is too numerous to list, only selected interesting find-
ings are highlighted.
In animals with tethered recordings, there is a set of be-
havioral parameters that show a high number of correlations. 
These comprise variables measured in the burrowing, social 
interaction, and saccharin preference test as well as food in-
take and weight gain. These variables not only show strong 
correlations with each other but also with variables from 
other tests such as the black‐white box, elevated‐plus maze, 
and the level of serum corticosterone and BDNF.
In animals with telemetric recordings, the interbehav-
ioral paradigm correlations are more scattered (Figure S9), 
with significant correlations found throughout more vari-
ables. When focusing on the relationship between heart 
rate variables and behavior, a clearer pattern emerges. 
Heart rate measures correlate with a number of behavioral 
parameters, but perhaps most noteworthy is that strong cor-
relations exist between behavioral and heart rate variables 
measured at different time points following SE. One ex-
ample is saccharin preference, measured at 12 weeks 
postinsult, which shows correlations with both heart rate 
and heart rate variability recorded only 1 week postinsult, 
while showing weaker correlations with the same parame-
ters measured at 4 and 9 weeks postinsult. The same ten-
dency can be observed with performance in the black‐white 
box and time spent in active social interaction. These pa-
rameters, measured 11 weeks post‐SE, exhibit stronger 
correlations with heart rate variables measured at 4 weeks 
post‐SE as compared to heart rate variables measured at 1 
or 9 weeks postinsult.
Moreover, correlations with seizure frequency and dura-
tion were tested. In animals with tethered recordings, there 
was a significant correlation between seizure frequency and 
duration and burrowing behavior, saccharin consumption, 
and head dips in the elevated‐plus maze performed during 
chronic phase. The strong correlation between seizure fre-
quency and duration and burrowing behavior and head dips 
was also observed in the telemetric recorded group. Moreover, 
a significant correlation between seizure frequency and dura-
tion and some of the heart rate variability parameters was 
F I G U R E  5  Heart rate (HR) and HR variability. A, C, Telemetric recordings of 2 days were performed at four different time points. Shown 
is the time‐based course of these parameters. B, D, Mean values of day and night were calculated and illustrated as boxplots for every time point. 
A, B Animals with a history of status epilepticus (SE) exhibited increased HRs in both dark and light phase during epileptogenesis (dark phase, 
P < .0001; light phase, P < .0001) and disease manifestation (dark phase, P = .0011; light phase, P = .0023). C, D, Standard deviation of NN 
intervals (SDNN) was significantly decreased in the dark and light phase in animals during epileptogenesis (dark phase, P = .0007; light phase, 
P = .0031). During the chronic phase, differences were only evident in the dark phase (P = .0187). Error bars indicate standard error of the mean. 
*P < .05, **P < .01, ***P < .001. Total n is sham, n = 6; post‐SE/epilepsy, n = 11
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observed, including RMSSD and pNN9, during light phase 
in the period of epilepsy manifestation.
3.8 | Comparison of tethered and 
telemetric monitoring
Although not the main aim of the study, an initial comparison 
can be made between the data obtained from animals monitored 
with a tethered recording and animals monitored with a telem-
etric recording system. Overall, few tests showed a difference 
of outcome after the period of monitoring (eg, different sham 
vs epilepsy group results). Different outcomes were seen in 
the saccharin preference test, nest‐building, weight of adrenal 
glands, and level of FCM (see Table S1 for the full overview).
Using data for parameters that were analyzed in animals 
with epilepsy from both the tethered and the telemetric record-
ings, a PCA was performed to obtain a first overview of pa-
rameters distinguishing the epilepsy groups with tethered and 
telemetric recordings (Figure 7 and Table S2 for an overview 
of abbreviations used). Taking into consideration that both 
subprojects were performed during different time points, this 
analysis offers only a first indication of differences that can 
F I G U R E  6  Correlation matrix. Spearman correlations between biochemical and behavioral parameters are illustrated with a heat map (For 
expansion of abbreviations refer to the table of abbreviations in the supplementary information)
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be further explored in future studies. In this PCA, only those 
data that were obtained immediately following the monitoring 
period were included, testing an immediate influence of the 
different monitoring setup on subsequent behavior and other 
biochemical parameters. Overall, the first two principal com-
ponents capture 41% of the variance in the data (PC1, 29%; 
PC2, 12%). The two groups are significantly different along 
PC2 (F1, 24  =  26.08, P  <  .001). The parameters contribut-
ing to this difference do not point toward a singular pheno-
type but rather comprise a mix of parameters from different 
experiments, that is, the top five contributing factors include 
nest‐building, time spent in passive social interaction, level of 
soiling, the level of BDNF, and level of corticosterone mea-
sured in serum.
4 |  DISCUSSION
Several experimental influences need to be considered when 
assessing the severity of chronic epilepsy models.5,8,26 For 
post‐SE models, respective experimental procedures com-
prise the surgical implantation of electrodes, the induction of 
the SE, and the video/EEG monitoring. The impact of these 
procedures on animals’ well‐being and condition during all 
phases of the chronic model need to be taken into account for 
the overall severity classification of the model.
Stereotactic implantation can exert consequences on an-
imal behavioral patterns also reflecting putative detrimental 
effects on well‐being.27,28 The comparison between elec-
trode‐implanted animals and naive control animals at various 
time points did not reveal relevant behavioral or biochemical 
alterations. These data are in line with our previous findings, 
in which animals with depth‐electrode implantation exhibited 
only very minor behavioral alterations 9 weeks after surgery.5
To assess the short‐ as well as long‐term consequences of 
SE, selected parameters were repeatedly analyzed allowing a 
comparison between experimental phases following SE.
In the chronic phase, several behavioral parameters 
showed alterations including reduced social interaction and 
saccharin preference in the subproject with tethered moni-
toring. These findings, together with an increase in adrenal 
gland weight at the end of the experiment, indicate that ani-
mals with epilepsy manifestation in the chronic phase of the 
pilocarpine model show an elevated level of distress.
Findings from assessment 7 days and 28 days following 
SE showed reduced burrowing activity, but unaltered nest‐
building, soiling, and normal or reduced FCM levels, param-
eters previously validated to be sensitive measures of change 
in stress and well‐being.14,29‒32
These results suggest that the impact on animals’ well‐
being is rather mild during this experimental phase in both 
subprojects. In this context, it is emphasized that in the 
F I G U R E  7  Principal component analyses. Data were considered for this analysis only that were measured following the seizure monitoring 
in animals that experienced status epilepticus during the chronic phase. Thereby, this analysis aimed to identify parameters that separate the two 
groups with tethered versus telemetric recordings. A, Principal component 1 is shown on the x‐axis, capturing 29% of the variance in the data. 
The y‐axis represents principal component 2, capturing 12% of the variance. Both groups are separated vertically on principal component 2. B, Top 
parameters best separating between the groups include nest‐building, time spent in passive social interaction, level of soiling, serum brain‐derived 
neurotrophic factor (BDNF), and serum corticosterone concentrations (For expansion of abbreviations refer to the table of abbreviations in the 
supplementary information)
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pilocarpine model this phase is characterized by single sei-
zures, so that the definition of an actual “latency” period is 
often difficult.
Taken together, our findings demonstrate an increased 
level of impairment in the very early postinsult phase and 
the chronic phase, and mild impairment of well‐being 
during the latency phase. As expected, the impact of the 
pilocarpine‐induced post‐SE model on animals’ well‐
being clearly exceeds that previously determined for the 
kindling paradigm.5 Considering the duration of the total 
experimental procedure, the complete experiment needs to 
be classified as severe, regardless of the monitoring setup 
used, according to the final report of a European expert 
working group in severity classification (http://ec.europa.
eu/envir onmen t/chemi cals/lab_anima ls/pdf/report_ewg.
pdf). In this context, it is emphasized that a suggestion for a 
classification can only serve as a recommendation, consid-
ering that the laboratory‐specific handling and experimen-
tal procedures as well as further factors including origin, 
strain, age, and sex of the animals can exert a relevant in-
fluence, thus requiring a laboratory‐specific classification. 
Refinement measures should be assessed that might help to 
minimize the severity conditions.8
In this context, it is of relevance to identify sensitive and 
robust parameters that should be included in severity‐assess-
ment schemes aiming to validate putative refinement mea-
sures and to classify new epilepsy models. Both nest‐building 
and burrowing have been discussed as nonessential behaviors 
that can serve as easy‐to‐use indicators of well‐being in lab-
oratory rodents.32‒37 In contrast to the persistent decrease of 
burrowing behavior throughout all experimental phases, an 
influence on nest‐building was only observed in the chronic 
phase in animals with preceding telemetric recordings. Thus, 
our findings suggest that burrowing behavior seems to be a 
more sensitive indicator of well‐being in chronic epilepsy 
models with induction of epileptogenesis. In this context, it 
should also be considered that SRSs might cause a bias in 
the chronic phase, because complex nests may be destroyed 
during generalized tonic‐clonic seizures. When considering 
burrowing behavior as a parameter, the effort for analysis 
needs to be taken into account. Although burrowing behavior 
in general can be easily assessed with a simple experimental 
setup, it requires a short training phase and baseline measure-
ments, and for rats the common procedure is based on analy-
sis in a separate cage and not the home cage.33,34,36,38
Among further paradigms, saccharin preference stands 
out as a low‐input paradigm that can be applied in the home 
cage, thereby avoiding any procedures that might exert more 
pronounced effects on readout parameters. The paradigm 
represents a comprehensively validated test to detect anhedo-
nia‐associated behavior in laboratory rodents.39‒41 Previous 
studies in epilepsy models have already demonstrated a re-
duction in the consumption of sweet solutions,40‒42 a finding 
that we confirmed in the group of rats with tethered record-
ings. It is of interest that saccharin preference remained un-
affected by kindled generalized seizures,5 indicating that the 
parameter might indeed help to distinguish between chronic 
epilepsy models with different severity. The various mea-
sures of hypothalamic‐pituitary‐adrenal (HPA) axis function-
ing did not result in a consistent conclusion, with the different 
measures indicating opposing or no differences between the 
different parameters and different subprojects. Complicating 
the interpretation further is the consideration that seizures 
can directly trigger activation of the HPA axis.43
Telemetric assessment of home cage activity, heart rate, 
and its variability has been suggested as an approach for 
assessment of distress in laboratory rodents.44‒47 The find-
ings from the present study partly confirm this suggestion, 
with increased dark phase activity evident during the early 
and late phase of epileptogenesis as well as increased heart 
rates throughout all day and experimental phases. However, 
only limited alterations of heart rate variability parameters 
were observed, with a decreased total variability. Thus, it re-
mains questionable whether it is worthwhile to apply highly 
time‐consuming and cost‐intensive telemetry procedures in 
addition to comprehensive behavioral analysis in severity as-
sessment studies.
Finally, the two cross‐correlation matrices analyzing all 
described parameters affirm both the burrowing and sac-
charin preference test as being robust behavioral paradigms, 
both of which show correlations with a number of costlier 
and more invasive and labor‐intensive measures such as the 
different telemetric measures. These correlations remain 
even with potentially larger variance in results from epileptic 
animals caused by spontaneous seizures on the day of behav-
ioral testing, as pre‐ and postictal alterations may affect dif-
ferent parameters. Besides the mentioned concerns of using 
HPA measures for severity assessment in this model, the cor-
relation matrices also suggest that the various biochemical 
parameters are poor indicators of burden, with only weak 
correlations with behavioral data, which reflect the affective 
and emotional state of the animal.
In this study, two different systems were used for the ac-
quisition of EEG. The tethered system was equipped with 
a swivel system to ensure high flexibility for the animals. 
Nevertheless, mobility was restricted to a certain extent. In 
contrast to this system, we also used telemetric devices where 
data are transferred without a tethered connection. It is as-
sumed that this wireless option could serve as a refinement 
measure, according to Lidster et al.8
Future studies are planned to address the refinement ques-
tion in detail. However, given the available data in the current 
study, an initial overview has been made, with little overall 
differences in outcome between the tethered and telemetri-
cally recorded animals. For a more compressive overview, a 
principal component analysis was run on parameters measured 
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immediately following either the traditional cable recording 
or the telemetric recording, allowing insight into where dif-
ferences can be found. Although separation between the two 
monitoring methods can be seen along PC2, the parameters 
contributing to this separation do not indicate a uniform set 
of behaviors but rather a mix of behavioral (eg, nest‐building, 
social interaction, level of soiling) and biochemical changes 
in the form of the level of BDNF and corticosterone in serum. 
The direction of changes observed is mixed as well, with some 
higher in the tethered group and others in the telemetry group. 
Future research is needed to dissect whether the specific 
changes observed are linked to a difference in well‐being or 
other possible factors such as the restriction in mobility.
In conclusion, the cumulative burden with temporary but 
not long‐lasting phases of a more pronounced impairment 
suggests a classification of severe as a basis for laboratory‐
specific prospective and retrospective evaluation. Among 
the parameters analyzed, burrowing behavior and saccharin 
preference stand out as candidate parameters that seem to be 
well suited to obtain information about the animal's distress 
in chronic epileptogenesis models.
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